secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0001193125-23-303014
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Enanta SVP & General Counsel Gardiner to retire by March 31, 2024; consulting role
--------------------------------------------------------------------------------

- Nathaniel S. Gardiner, age 70, plans to retire as SVP and General Counsel on or before March 31, 2024.
- Company expects to enter a consulting agreement with Gardiner for up to one year post-retirement.
- No successor has been named; search process not disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000119312523303014/0001193125-23-303014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000119312523303014/d308147d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-303014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer